Cutting-edge research reveals new therapeutic targets and treatments for neurological conditions. A study from KAIST highlights gut microbiota’s role in boosting glioblastoma immunotherapy efficacy. Researchers used AI-driven drug discovery to identify vorinostat, an HDAC inhibitor, as a promising drug candidate across neurological and other systems for Rett syndrome. In Parkinson’s disease, advanced MRI techniques delineate microstructural putamen changes, while studies reveal genetic links between PTSD and cardiovascular health. Additionally, scientists uncover the lasting presence of neurogenesis and neural precursor cells in adult human brains, settling longstanding scientific debates.